17 Many employers have excluded weight loss drugs from their health insurance plans due to the high costs associated with treating large numbers of people.6,7 Patients typically pay $100 to $450 a month for a compounded version, compared with list prices of roughly $1,000 to $1,400 monthly for name brand products
Stambolija V, Stambolija TP, Holjevac JK, Murselovic T, Radonic J, Duzel V, et al
The cagrilintide dosage with retatrutide would theoretically combine amylin pathway activation with this triple-agonist approach
Brace yourself for the body image and self-image shifts post weight loss and skin removal surgery
In the SURMOUNT-1 trial (Jastreboff et al., NEJM 2022), adults with obesity (without diabetes) receiving tirzepatide 15 mg weekly achieved a mean weight loss of 20.9% over 72 weeks, compared to 3.1% with placebo